Anti-tumor activity studies of vinorelbine tartrate liposome
- Author:
Cai-Xia WANG
1
Author Information
- Publication Type:Journal Article
- Keywords: Anti-tumor effect; H22; Liposome; NCI-H460; Vinorelbine
- From: Chinese Pharmaceutical Journal 2013;48(20):1733-1736
- CountryChina
- Language:Chinese
- Abstract: OBJECTIVE: To explore the anti-tumor efficacy of liposomal vinorelbine tartrate injection(NVB-lipo). METHODS: The anti-neoplastic effect of NVB-lipo was evaluated by using mice bearing H22 tumor and nude mice bearing NCI-H460 human xenograft tumor model. RESULTS: After a single intravenous injection at doses of 20, 10, 5 and 2.5 mg · kg-1, the inhibition ratio of H22 tumor were 82.1%, 75.8%, 63.2% and 35.4% respectively, and that of NVB-free(20 and 10 mg · kg-1) were 45.8% and 37.1%. After three times iv injection interval 3-day, NVB-lipo 8 mg · kg-1 could markedly inhibited the growth of NCI-H460 tumor, relative to control and NVB-free (P < 0.05). The anti-tumor effect of NVB-lipo in H22 and NCI-H460 tumor model was much stronger than NVB-free, and was positively correlated with its dose levels. CONCLUSION: At the same dose level, the antineoplastic effects of NVB-lipo is stronger than NVB-free.
